Webinar: PrEP in 2019: News You Can Use
Facilitated by Christopher B. Hurt, MD
Assistant Professor of Medicine
University of North Carolina at Chapel Hill
September 11, 2019
Objectives
- Summarize some of the new data on PrEP from scientific conferences in 2019
- Identify the differences and similarities of FTC/TDF and FTC/TAF for PrEP
- Discuss how HIV prevention advocates have approached issues related to pricing and availability of PrEP in the US
- Explain the controversy over patents for PrEP and the meaning of the Truvada lawsuits
- Describe the potential impact of the US Preventive Services Task Force’s new recommendation for PrEP
Presentation
Slides
Facilitated by Christopher B. Hurt, MD
Assistant Professor of Medicine
University of North Carolina at Chapel Hill
September 11, 2019
Objectives
- Summarize some of the new data on PrEP from scientific conferences in 2019
- Identify the differences and similarities of FTC/TDF and FTC/TAF for PrEP
- Discuss how HIV prevention advocates have approached issues related to pricing and availability of PrEP in the US
- Explain the controversy over patents for PrEP and the meaning of the Truvada lawsuits
- Describe the potential impact of the US Preventive Services Task Force’s new recommendation for PrEP
Presentation
Slides
Facilitated by Christopher B. Hurt, MD
Assistant Professor of Medicine
University of North Carolina at Chapel Hill
September 11, 2019
Objectives
- Summarize some of the new data on PrEP from scientific conferences in 2019
- Identify the differences and similarities of FTC/TDF and FTC/TAF for PrEP
- Discuss how HIV prevention advocates have approached issues related to pricing and availability of PrEP in the US
- Explain the controversy over patents for PrEP and the meaning of the Truvada lawsuits
- Describe the potential impact of the US Preventive Services Task Force’s new recommendation for PrEP
